Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.6.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities:      
Net loss $ (2,868) $ (3,600) $ (7,834)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation 426 367 277
Amortization of loan origination and warrant expenses 24
Gain on the sale of fixed assets (9) (6)
Impairment charge 3,577
Share-based compensation expense 1 135 1,044
Changes in operating assets and liabilities:      
Accounts receivable (1,770) 1,836 (517)
Inventory 1,595 (1,039) (771)
Prepaid expenses and other assets 1,204 (480) 397
Accounts payable 1,166 323 (344)
Accrued advertising and other allowances 297 (1,177) 838
Other operating assets and liabilities, net (547) 147 123
Net cash used in operating activities (472) (3,497) (3,216)
Cash flows from investing activities:      
Capital expenditures (651) (718) (312)
Proceeds from the sale of fixed assets 9 6
Net cash flows used in investing activities (651) (709) (306)
Cash flows from financing activities:      
Proceeds from issuance of common stock 1,564 4,910
Payment of long term obligation (100) (100) (100)
Secured promissory note issuance costs (20)
Proceeds from secured promissory note 1,500
Net cash provided by (used in) financing activities (100) 2,944 4,810
Net increase (decrease) in cash and cash equivalents (1,223) (1,262) 1,288
Cash and cash equivalents at beginning of year 1,664 2,926 1,638
Cash and cash equivalents at end of year 441 1,664 2,926
Supplemental disclosures of cash flow information:      
Interest paid 190 6 10
Issuance of warrants in connection with secured promissory notes 14
Treasury stock acquired pursuant to a settlement agreement 5,105
Common stock issued, in lieu of cash, as payment for service $ 393